Zavesca
What is Zavesca?
Miglustat (OGT 918, N-butyl-deoxynojirimycin) is a drug developed by Oxford GlycoSciences and marketed by Actelion and is used primarily to treat type I Gaucher disease (GD1). It is marketed under the trade name Zavesca.
Questions and answers on "Zavesca"
Recent questions on Zavesca
Explore "Zavesca"
Related Disease & Conditions
Related Drugs/Medications
Related Lab Tests
Related Procedures